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Two point mutations (TNG and TNC) at the same 8993 nucleotide of mitochondrial DNA (at comparable mutant load), affecting the ATPase 6
subunit of the F1F0-ATPase, result in neurological phenotypes of variable severity in humans. We have investigated mitochondrial function in
lymphocytes from individuals carrying the 8993TNC mutation: the results were compared with data from five 8993TNG NARP (Neuropathy,
Ataxia and Retinitis Pigmentosa) patients. Both 8993TNG and 8993TNC mutations led to energy deprivation and ROS overproduction. However,
the relative contribution of the two pathogenic components is different depending on the mutation considered. The 8993TNG change mainly
induces an energy deficiency, whereas the 8993TNC favours an increased ROS production. These results possibly highlight the different
pathogenic mechanism generated by the two mutations at position 8993 and provide useful information to better characterize the biochemical role
of the highly conserved Leu-156 in ATPase 6 subunit of the mitochondrial ATP synthase complex.
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NARP (Neuropathy, Ataxia, and Retinitis Pigmentosa) and
MILS (Maternally Inherited Leigh's Syndrome) are progressiveAbbreviations: F0, membrane sector of the F1F0-ATPase complex; F1,
catalytic sector of the F1F0-ATPase complex; CS, citrate synthase; SODs, Mn-
and CuZn-superoxide dismutases; ROS, reactive oxygen species; RH-123,
Rhodamine-123; JC-1, 5,5′,6,6′-tetrachloro-1,1′,3,3′tetraethylbenzimidazolo-
carbocyanine iodide; FCCP, carbonylcyanide-4-(trifluoromethoxy)-phenylhy-
drazone; CM-DCFDA, 5-(and -6) chloromethyl-2,7-dichlorofluorescein
diacetate; ΔΨm, mitochondrial electrical membrane potential; PBMCs,
Peripheral Blood Mononuclear Cells; FQR, fluorescence quenching rate;
PCR, polymerase chain reaction; RFLP, restriction fragment length polymorph-
ism; NARP, Neuropathy, Ataxia and Retinitis Pigmentosa; MILS, Maternally
Inherited Leigh Syndrome
⁎ Corresponding author. Tel.: +39 051 2091215; fax: +39 051 2091224.
E-mail address: giancarlo.solaini@unibo.it (G. Solaini).
0005-2728/$ - see front matter © 2007 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbabio.2007.05.005neurodegenerative disorders of infancy and early childhood [1].
Clinical features of NARP may variably include peripheral
neuropathy, retinitis pigmentosa, cerebellar atrophy, mental
retardation, and less frequently epileptic seizures, cardiomyo-
pathy, deafness and optic atrophy. MILS is dramatically
characterized by bilateral subacute lesions of the basal ganglia,
which extending to the brainstem, lead to death of the patient.
Point mutations (TNG and TNC) at nucleotide 8993 of
mtDNA, affecting the ATPase 6 subunit of the F1F0-ATPase
(ATP synthase), have been associated with both syndromes, and
are always found as heteroplasmic mutations (wild-type and
mutant mtDNA coexist within the same cell or tissue). Recent
studies indicate a tight correlation between clinical, genetic and
biochemical features in patients carrying variable loads of the
mtDNA 8993TNG transversion [2,3]), and suggest that
reduction in the rate of ATP synthesis is a major contributor
to the pathomechanism of this mutation [4].
Fig. 1. Mitochondrial DNA mutant load in lymphocytes of 8993TNC patients.
Electrophoretic gel showing the HpaII digestion of PCR products. mtDNA
heteroplasmy was evaluated by relative densitometric quantification of the
HpaII digested fragments. TOP Pedigrees of the Italian family investigated: the
grey symbol indicates the carrier of the mutation with non-specific NARP
symptoms; the dark grey symbol, the NARP patient. Note that the mutant loads
after correction for the heteroduplex artefact were estimated up to 30% and 94%
for the proband's mother (I-1) and the proband (II-1).
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transition leads to similar NARP/MILS phenotypes, although in
a milder form [5]. Neither the pathogenic mechanism, nor the
biochemical effect of the 8993TNC mutation are fully under-
stood. Some reports indicate that the maximal rate of ATP
production is only slightly decreased in cells from patients and
in transmitochondrial cytoplasmic hybrids (cybrids) carrying
the 8993TNC mutation [6,7]. This suggests that the pathome-
chanism for the latter mutation may not be exclusively linked to
a decrease in ATP production.
Mutations in mtDNA or nDNA that affect oxidative
phosphorylation (OXPHOS) may induce overproduction of
free radicals (reactive oxygen species, ROS) [8,9]. Oxidative
stress, resulting from the imbalance between ROS formation
and antioxidant defences, plays a major role in the pathogenesis
of neurological diseases related to mitochondrial dysfunction
(for recent reviews, see [10,11]). Intriguingly, both cells of
patients and cybrids carrying the 8993TNG mutation displayed
an abnormal production of ROS, irrespective of effects in
mitochondrial membrane potential [12,13]. To better under-
stand the pathogenic mechanism of the 8993TNC mutation we
compared mitochondrial function of lymphocytes derived from
two variably affected individuals harbouring different mutant
loads with that of five NARP or NARP/Leigh patients carrying
the 8993TNG heteroplasmic mutation. We report here the
measurement of ATP synthesis rate in permeabilized lympho-
cytes, the fluorometric evaluation of mitochondrial electrical
membrane potential (ΔΨm) by both flow cytometry and
fluorescence quenching analysis, and we relate the bioener-
getics of 8993TNC mutant cells to ROS production and pattern
of ROS-detoxifying enzymes. Based on the current results we
suggest that increased oxidative stress may play a major
contribution to the pathomechanism associated with the
8993TNC mutation. Furthermore, the present results provide
useful information on the importance of the Leu-156 residue
within the ATPase 6 subunit of the mitochondrial ATP synthase.
2. Materials and methods
2.1. Patients
All patients were previously reported. The five 8993TNG NARP patients
are the same as in Carelli et al. [3] and Sgarbi et al. [4]. The 8993TNC family has
been recently reported by Sciacco et al. [14]. This latter family is composed by a
female NARP proband (subject II-1 in Fig. 1) and her mother (I-1 in Fig. 1). The
proband is a 30-year-old woman, currently suffering of visual loss due to
retinitis pigmentosa, sensorineural deafness, cerebellar ataxia, muscle weakness,
and mild mental retardation. Her mother, a 53-year-old woman, is short and
suffering a mild form of peripheral neuropathy, confirmed by neurophysiolo-
gical investigations. Finally, a proband's sister died at 3 years of age with
encephalopathic features compatible with the diagnosis of Leigh syndrome.
2.2. Cell culture
PBMCs (Peripheral Blood Mononuclear Cells) were obtained by Ficoll-
Hypaque Plus centrifugation of EDTA-treated blood, washed twice in PBS
(Phosphate Buffered Saline) and resuspended in RPMI 1640 medium
supplemented with 10% heat inactivated FBS (Fetal Bovine Serum), 50 IU/ml
penicillin and 50 mg/ml streptomycin. PBMCs (106 cells/ml) were cultured in T-
75 flasks for 3 h at 37 °C in a humidified incubator. Lymphocytes (non adherentcells) obtained as previously reported [4]) were cultured for 48 h. Viability was
usually around 90% in both control and patient cells and cell population
homogeneity (95% lymphocytes) was assessed by flow cytometry.
2.3. Mitochondrial DNA analysis
Total DNA was extracted from a pellet of the same lymphocytes used for
biochemical investigations by means of the standard phenol-chloroformmethod.
The point mutations at nt8993 were detected by restriction fragment length
polymorphism (RFLP) analysis using the restriction endonucleases AvaI for the
8993TNG mutation and HpaII for the 8993TNC mutation followed by
electrophoresis, as previously reported [3,15]. Quantitative evaluation of the
mutant loads in patients with 8993TNG mutation has been previously reported
by Carelli et al. [3]. In the case of the two subjects carrying the 8993TNC
mutation we evaluated the mutant loads by densitometry on the agarose gels
stained with ethidium bromide as reported by Baracca et al. [15], followed by a
mathematical correction for the heteroduplex PCR artefact as suggested by
Shoffner et al. [16].
2.4. ATP synthesis and citrate synthase assay
Mitochondrial ATP synthesis rate in digitonin-permeabilized lymphocytes
was assayed as recently detailed [4]. Briefly, lymphocytes (20×106 cells/ml)
were incubated for 20 min at room temperature with 60 μg/ml digitonin, 2 mM
iodoacetamide, and the adenylate kinase inhibitor, P1,P5-Di(adenosine-5′)
pentaphosphate pentasodium salt (25 μM)), in 10 mM Tris/Cl (pH 7.4),
100 mM KCl, 5 mM KH2PO4, 1 mM EGTA, 3 mM EDTA, 2 mM MgCl2.
Complex II driven ATP synthesis was induced adding 20 mM succinate, 4 μM
rotenone, and 0.5 mM ADP to the sample. The reaction was carried out at 30 °C
and after 5 min it was stopped by addition of 80% dimethylsulfoxide. ATP
synthesized was extracted from the cell suspension and assayed by the
luminometric method as described by Stanley and Williams [17]: as a blank a
sample not energized with succinate, but containing both 18 μM antimycin A
and 2 μM oligomycin was used. Digitonin concentration was chosen as a result
of a careful analysis to minimize any possible side effect.
Citrate synthase activity was quantified essentially according to Trounce
et al. [18].
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Cytofluorometric analysis of mitochondrial membrane potential was
performed in intact lymphocytes with 5,5′,6,6′-tetrachloro-1,1′,3,3′tetraethyl-
benzimidazolocarbocyanine iodide (JC-1) (Molecular Probes, Eugene, OR) on
the Epics Elite (Beckman-Coulter) flow cytometer equipped with a 15 mW
argon laser. Cells washed twice in PBS and re-suspended at 5×105 cells/ml in
RPMI 1640 medium were incubated with 2 μM JC-1 for 30 min at 37 °C. The
dye is electrophoretically accumulated in mitochondria, and after excitation at
488 nm the fluorescence emission was detected at both 525 nm (JC-1
monomeric form) and 575 nm (aggregate). A minimum of 10.000 events were
acquired in linear scale for each measurement and the data were analysed with
the cytometer software. When used, 2 μM oligomycin was pre-incubated with
cells at 37 °C for 5 min.
The steady state mitochondrial electrical potential of permeabilized
lymphocytes was assessed by means of the fluorescent cationic dye
Rhodamine-123 (RH-123), which distributes electrophoretically into the
mitochondrial matrix in response to the electrical potential across the inner
mitochondrial membrane [19]. Briefly, lymphocytes (4×106/ml) suspended in a
respiratory buffer (250 mM sucrose, 10 mM HEPES, 0.1 mM K-EGTA, 2 mM
MgCl2, 4 mM KH2PO4, pH 7.4) containing an ADP regenerating system
(5 U/ml hexokinase and 10 mM glucose) and 50 nM Rhodamine-123 were
incubated with 33 nM cyclosporine A, 2.5 μM rotenone, 200 μMADP and then
permeabilized adding 15 μg/ml digitonin. RH-123 fluorescence decay kinetics
(λexc=503 nm; λem=527 nm) were induced by the addition of 20 mM succinate
to the sample either pre-incubated (state 4 respiratory condition) or not (state 3
respiratory condition) with 2 μM oligomycin. Further details on reliability and
suitability of the method for ΔΨm measurements are reported in Baracca et al.
[20].
2.6. Mn-SOD, Cu/Zn-SOD and catalase activity assays
Lymphocytes (10–15×106 cells/ml) were suspended in phosphate buffer
(50 mM KH2PO4, pH 7.8) containing 0.1% bovine serum albumin and the
protease inhibitor cocktail (Sigma), and exposed to sonic oscillation at
maximum output of a Brown apparatus for 45 s, in 15 s burst, at 4 °C. After
centrifugation at 100,000×g for 30 min, the activity of both Mn-SOD and Cu/
Zn-SOD was measured in the supernatant according to Oberley and Spitz [21].
Since the Mn-SOD is a mitochondrial enzyme, comparison of its activity in
control and in patient cells was done following normalisation with respect to the
activity of citrate synthase, which is a general marker for mitochondrial volume
in cells. The catalase activity was measured spectrophotometrically at 240 nm
following the hydrogen peroxide decomposition according to Aebi et al. [22]
and the cyanide-sensitivity of the enzyme was assessed in the presence of
0.2–0.4 mM KCN, as suggested by Heck et al. [23].
2.7. Protein determination
Protein concentration of samples was assessed by the method of Lowry et al.
[24] in presence of 0.3% (w/v) sodium deoxycholate. Bovine serum albumin
was used as standard.
2.8. ROS detection
Lymphocytes were incubated for 24 h in Dulbecco's modified Eagle
medium (D-MEM) (devoid of both pyruvate and glucose) and 5% heat
inactivated and dialyzed FBS containing either 10 mM glucose or 5 mM D-
galactose and 110 mg/l pyruvate. The cells were then pelleted and re-suspended
at 0.5–1×106 cells/ml in 10 mM HEPES, 142 mM NaCl, 2 mM KCl, 1.2 mM
KH2PO4, 1 mM MgSO4, 1.3 mM CaCl2, pH 7.4 and either of the two above
substrates, and finally cells were incubated with 5 μM 5-(and -6) chloromethyl-
2,7-dichlorofluorescein diacetate (CM-DCFDA) for 30 min at 37 °C. Reactive
species production was detected by measuring the fluorescence emission at
535 nm in a Wallac Victor2 1420 multilabel counter (Perkin-Elmer), according
to a slightly modified method of Degli Esposti [25]. ROS detection was
occasionally carried out by incubating the cells for 2 h in the presence of 2 μM
carbonylcyanide-4-(trifluoromethoxy)-phenylhydrazone (FCCP).2.9. Statistical analysis
All results are expressed as mean±SD. Statistical significance of differences
between sample populations was evaluated using one-way ANOVA followed by
the Bonferroni post-test using a statistical software program (OriginPro 7.5,
OriginLab Corporation, MA, USA) for multiple comparison tests. Statistical
differences of p≤0.05 were considered to be significant.
3. Results
3.1. Mitochondrial DNA analysis of cells
Molecular analysis of lymphocytes mtDNA from the two
subjects carrying the 8993TNC mutation is shown in Fig. 1,
whereas for all the other patients we referred to the previously
reported evaluations [3,4]. Overall, the 8993TNG patients
ranged between 79% and 94% mutant loads. Concerning the
densitometric evaluation of the two 8993TNC subjects, the
mutant loads were estimated as 9% and 93%, which corrected
for the heteroduplex PCR artifact were about 30% and 94% for
the proband's mother (I-1 in Fig. 1) and the proband (II-1 in Fig.
1), respectively [16].
3.2. Rate of ATP synthesis in digitonin-permeabilized
8993TNC heteroplasmic cells
The main function of mitochondria is to synthesize ATP. The
process is catalyzed by the ATP synthase and it is thermo-
dynamically driven by the electrochemical proton gradient
across the inner membrane. In normally functioning mitochon-
dria, the ΔΨm is generated by the proton translocation from the
matrix to the intermembrane space coupled with the electron
transfer from reduced nicotinamide and flavin mononucleotides
to oxygen, which is carried out by the respiratory chain
complexes. To correlate ATP synthesis with mutant load, we
measured mitochondrial ATP synthesis rate in digitonin-
permeabilized cells energized with succinate. Fig. 2 shows
that ATP synthesis decreases only 20% in lymphocytes carrying
the 8993TNC mutation from the patient with 94% hetero-
plasmy. The patient's mother, carrying 30% mutant load, was
not affected. By contrast, the rate of ATP synthesis in
lymphocytes from five 8993TNG NARP patients (79–94%
mutant load) decreases 65% or more compared with controls.
3.3. Membrane potential of mitochondria carrying the
8993TNC mutation
The synthesis of ATP by the mitochondrial ATP synthase
slightly decreases ΔΨm by utilizing the proton current,
therefore it follows that inhibition of ATP synthase will
hyperpolarize the mitochondria; addition of the specific ATP
synthase inhibitor oligomycin acutely hyperpolarizes the
mitochondria. Conversely, mitochondria that have inhibited
respiratory chains or that have leaky inner membranes can
reverse the ATP synthase to maintain a suboptimal ΔΨm by
hydrolyzing glycolytic ATP. By monitoring the initial rate of
Rhodamine 123 (RH-123) fluorescence quenching induced by
respiration, a quantitative estimation of the mitochondrial mem-
Fig. 2. Rate of ATP synthesis by permeabilized 8993TNC/G lymphocytes
energized with succinate. Data reported for individuals harbouring the
8993TNC mutation are presented as mean±SD of three determinations on
each lymphocyte preparation, whereas mean±SD of two to four assays are
reported in single dots for each control and 8993TNG patient. Dots represent
mean values of each individual.
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the mitochondrial matrix by the respiratory complexes into the
intermembrane space, and easily diffuse back in through F0.
However, a significant fluorescence quenching is maintained at
steady state as a balance between activities of respiration and
proton flow through F0. The initial rate of respiration-induced
RH-123 fluorescence quenching increases with increasingΔΨm
[20].
The membrane potential generated by proton movements
across the inner mitochondrial membrane in digitonin-permea-
bilized lymphocytes of two individuals carrying the 8993TNCFig. 3. Mitochondrial membrane potential in digitonin-permeabilized lympho-
cytes of individuals harbouring the mtDNA 8993TNC/G mutation. (ΔF/Fi/sec)
is an expression of the decay rate of RH-123 fluorescence, strictly related with
ΔΨm [20]. Mean±SD of three measurements on each sample preparation of
TNC patients is reported in presence or absence of oligomycin, whereas mean±
SD of two to four assays are reported in single dots for each control (n=12) and
TNG patient (n=5) both exposed or not to oligomycin. Asterisks indicate
statistically significant differences (pb0.01) between patient and control
lymphocytes or between oligomycin-treated and untreated lymphocytes. Dots
represent mean values of each individual.mutation was evaluated and compared with controls and
patients harbouring the 8993TNG mutation. Fig. 3 shows the
rate of RH-123 fluorescence decay upon energization with
succinate under conditions of maximal ADP phosphorylation
(state 3 respiration) for mitochondria from normal or mutant
permeabilized lymphocytes. In the mutant cells, a slightly
higher level of mitochondrial ΔΨm was observed during ADP
phosphorylation. In TNC mutant lymphocytes, the increase
reached statistical significance only when heteroplasmy was
94%. A significant increase was also observed in the TNG
mutant lymphocytes. Clearly, oligomycin enhanced mitochon-
drial ΔΨm to a much higher extent than the mutations,
indicating an impairment of proton translocation through the
mutant F0, which however is far from the block of F0 proton
permeability as induced by the specific ATP synthase inhibitor
oligomycin.
The mitochondrial ΔΨm of intact cells kept in glucose
medium was analysed by cytofluorometry using the membrane
potential-sensitive cationic probe JC-1. The ΔΨm of 8993TNC
mutant cells was similar to controls (Fig. 4a and c, top, and Fig.
4, bottom), whereas ΔΨm of cells with the 8993TNG mutation
was increased compared to controls (Fig. 4a and b, top, and Fig.
4, bottom), suggesting that under condition of low energy cell
demand, the TNG mutant cells, having ATP synthesis by
OXPHOS severely reduced, possibly produce ATP onlyFig. 4. Mitochondrial membrane potential of intact lymphocytes carrying the
8993TNG and TNC mutation. Cytofluorometric analysis of ΔΨm was
performed in glucose-grown intact lymphocytes previously loaded with 2 μM
JC-1. TOP Left panel, a, typical dot plot of controls; centre panel, b, typical dot
plot of 8993TNG mutant cells; right panel, c, typical dot plot of 8993TNC
mutant cells. Dots in region 3 indicate cells expressing low red fluorescence
(corresponding to J-aggregates), which increases when mitochondrial mem-
brane becomes hyperpolarized, as in b. BOTTOM Quantification of cytofluoro-
metric data is shown. Mean values±SD of JC-1 fluorescence ratio (F575/F525) of
lymphocytes examined in presence and absence of 2 μM oligomycin are
reported. Dots represent mean values of each individual.
Fig. 5. ROS production in intact lymphocytes of 8993TNG/C patients. Reactive
species were evaluated by measuring CM-DCFDA fluorescence in cells
maintained with media containing glucose/pyruvate (a), or galactose/pyruvate
(b) substrates. Bars represent means±SD of triplicates carried out on 12
controls, the five NARP patients carrying the 8993TNG mutation, and the
8993TNC patients. Dots represent mean values of each individual.
Fig. 6. Antioxidant enzyme activities in lymphocytes of 8993TNG/C patients.
Activities were measured as detailed in Materials and methods. (a) The
mitochondrial Mn-SOD was normalised by citrate synthase to take account of
the mitochondrial mass in different cells, (b) CuZn-SOD and (c) catalase
activity. Values are mean±SD obtained from duplicate measurements on 12
controls, and 7 individuals carrying 8993TNG (n=5) and 8993TNC (n=2)
mutations. Dots represent mean values of each individual.
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mutant cells, similarly to controls, can satisfy the energy
demand by predominantly using the oxidative phosphorylation
process. This interpretation finds support on the observation
that oligomycin pre-treatment of cells results in a JC-1
fluorescence ratio increase in both controls and TNC mutant
cells reaching a value similar to the fluorescence ratio of
untreated TNG mutant cells (Fig. 4, bottom).
3.4. ROS overproduction and enhanced activity of detoxifying
enzymes in lymphocytes from NARP patients
ROS levels are affected by rates of ROS production (mostly
via respiratory chain complexes) and ROS destruction by
detoxifying enzymes, including superoxide dismutases.
Impaired energy conservation, and increased ΔΨm values in
mitochondria, are often accompanied by increased ROS
production as the electron transfer compounds become over
reduced. ROS levels were measured in the mutant cells using
the fluorescent probe CM-DCFDA [25]: the fluorescence of the
probe incubated for 30 min with lymphocytes of controls and
patients carrying the two mutations is reported in Fig. 5. TNG
NARP cells grown in glucose medium (Fig. 5a) produced about
50% more ROS than controls, whereas TNC NARP cells
showed double ROS production. Under conditions in which
ATP synthesis depends primarily on oxidative metabolism, that
can be induced by growing cells in the absence of glucose,
NARP cells with either mutation showed a similar 2-fold
enhancement compared to controls (Fig. 5b).
In NARP TNG mutated cells the activity of both CuZn-SOD
and mitochondria-compartmentalized Mn-SOD, the latterexpressed as the ratio between Mn-SOD and citrate synthase
(CS) activity, increased compared to control cells (pb0.05)
(Fig. 6a, b). In NARP TNC mutated cells both SOD activities
showed a mild tendency to increase, but the enhancement was
not statistically significant (Fig. 6a, b). Moreover, catalase
activity did not change significantly in any of the NARP
samples (Fig. 6c).
4. Discussion
We here report on the biochemical phenotype associated
with the 8993TNCmutation in circulating lymphocytes, and the
results are compared to those of the better characterized
8993TNG mutation.
Predictably, ATP synthesis rate was only mildly reduced by
the 8993TNC mutation at 94% heteroplasmy, thus not fully
explaining the severity of NARP and MILS phenotypes seen in
patients. Similarly, only 22% reduction of ATP synthesis rate
has been previously reported in homoplasmic 8993TNC
cybrids [7]. Thus, a bioenergetic defect is unlikely to be the
main reason for the disease pathogenesis. In account for
pathogenesis, additional mechanisms must be considered.
In intact cells of 8993TNG NARP patients, the ΔΨm was
significantly increased compared to controls (Fig. 4), whereas
ΔΨm of cells carrying the 8993TNC mutation was close to
normal, in agreement with Vilarinho et al. [26]. Nonetheless,
ROS levels sharply increased in glucose-grown lymphocytes
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(m.l.) and +30% at 30% m.l. compared to controls) but only
moderately with the 8993TNG mutation (+50% at m.l. above
79%). The strong increase of ROS in cells carrying either
mutation occurred concurrently with a tendency to increased
SOD activities. Our results on both ROS cellular level and SOD
activities in 8993TNG and 8993TNC mutant cells are only
apparently in contrast since increased SOD activities could
enhance the hydrogen peroxide level without significant effects
on DCFDA fluorescence due to different sensitivity of the probe
towards the biological reactive species: in particular it promptly
detects reactive species as hydroxyl radical and peroxynitrite
[27].
The prevailing hypothesis to explain ROS overproduction in
mutant mitochondria is an accumulation of reduced species
within redox centres of complexes I and III of the respiratory
chain associated with increased ΔΨm [8]. Accordingly, the
results here presented show an enhanced endogenous ΔΨm
under condition of maximal ATP synthesis rate (i.e. state 3
respiration) in mutant cells (Fig. 3), and concurrently ROS
levels are higher compared to controls (Fig. 5b).
In glucose-grown intact cells, ROS were observed at higher
concentration in 8993TNC than in NARP 8993TNG mutant
cells (Fig. 5a), whereas ΔΨm was higher than controls only in
8993TNG mutant cells (Fig. 4). This might be the consequence
of the different metabolic pathway used by 8993TNG mutant
cells with respect to 8993TNC and control cells under condition
of both low energy requirement and glucose availability as
metabolic substrate. In fact in 8993TNG mutant cells most ATP
is produced by anaerobic glycolysis since oxidative phosphor-
ylation rate is highly decreased. Therefore the electron flow
through the respiratory chain is severely reduced, consequently
the uncontrolled electron leak may be minimized. This is
consistent with the observation that in digitonin-permeabilized
8993TNG mutant cells the respiration rate under phosphorylat-
ing condition is over 40% reduced [7,13,28], whereas in
8993TNC mutant lymphocytes from the NARP patient, the
respiration rate is only 16% lower than controls [unpublished
results], in agreement with data we previously reported for
cybrids [7]. The occurrence of reduced electron flow through
the respiratory chain (induced by the ATP synthase impairment)
together with the mainly aerobic metabolism of the 8993TNC
mutant cells might give reason for the overproduction of ROS
with respect to both 8993TNG and control lymphocytes as
grown in glucose medium. This interpretation is consistent with
the idea that mitochondria highly contribute to ROS production
in 8993TNC NARP cells. To support this hypothesis, we
analysed the uncoupler (FCCP) effect on the DCFDA
fluorescence of 8993TNC lymphocytes grown in glucose
medium. We found that the DCFDA fluorescence of FCCP-
treated cells was 39% and 33% reduced in 8993TNC and
control lymphocytes, respectively. Therefore, FCCP similarly
prevented ΔΨm-dependent ROS production in both 8993TNC
and control lymphocytes. To account for the overall ROS
production in 8993TNC mutant cells, we suggest that other
mechanisms are involved, including loss of electrons due to
impaired respiratory chain complexes, as observed by Mattiazziet al. [13] in cells carrying the 8993TNG mutations, and
dysfunction of the alfa-ketoglutarate dehydrogenase complex
under conditions of altered NAD(P)H/NAD(P)+ ratios [29], that
likely occurs in cells harbouring mtDNA mutations.
Based on the present results, we suggest that ROS over-
production is a major pathogenic mechanism contributing to the
occurrences of NARP and MILS phenotypes with the TNC
mutation at position 8993 of the ATPase 6 subunit gene.
Although overproduction of ROS is also reported in 8993TNG
NARP cells [13], the dramatic bioenergetic impairment shown
by these cells [4,15] suggest the energy deficiency as the
prevalent component of the pathomechanism. The difference in
biochemical behaviour of the two distinct nucleotide changes at
the same 8993 mtDNA position may justify the less severe
phenotype and possibly a later onset of symptoms in the
presence of similar mutant loads associated with the 8993TNC
mutation. A further element that may induce a slightly different
clinical expression of the two mutations, and possibly a
different severity in the tissues involved, may be the specific
capability of different cell types to cope with increased ROS,
deficient ATP synthesis or various combinations of both
pathogenic components.
In summary, a battery of biochemical experiments performed
in the present study demonstrated that different pathogenic
mechanisms may be generated by two different mutations at the
same position of the ATP 6 gene of mtDNA, which might lead
to different pharmacological avenues to the treatment of the
associated mitochondrial disease. In addition, the present results
might help to characterize the structural and/or the functional
role of Leu-156 of the ATPase 6 subunit of the human
mitochondrial ATP synthase.
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